PMC:7555630 / 18025-18325 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T157","span":{"begin":74,"end":82},"obj":"Disease"},{"id":"T158","span":{"begin":215,"end":223},"obj":"Disease"}],"attributes":[{"id":"A157","pred":"mondo_id","subj":"T157","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A158","pred":"mondo_id","subj":"T158","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Rejdak and colleagues then identified 22 patients who tested positive for SARS-CoV-2 and were taking either amantadine or memantine, and reported that none of these patients developed any clinical manifestations of COVID-19, nor did they report any significant change in their neurologic status [24]."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T92","span":{"begin":38,"end":40},"obj":"http://purl.obolibrary.org/obo/CLO_0050507"},{"id":"T93","span":{"begin":54,"end":60},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"}],"text":"Rejdak and colleagues then identified 22 patients who tested positive for SARS-CoV-2 and were taking either amantadine or memantine, and reported that none of these patients developed any clinical manifestations of COVID-19, nor did they report any significant change in their neurologic status [24]."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T38","span":{"begin":108,"end":118},"obj":"Chemical"},{"id":"T39","span":{"begin":122,"end":131},"obj":"Chemical"}],"attributes":[{"id":"A38","pred":"chebi_id","subj":"T38","obj":"http://purl.obolibrary.org/obo/CHEBI_2618"},{"id":"A39","pred":"chebi_id","subj":"T39","obj":"http://purl.obolibrary.org/obo/CHEBI_64312"}],"text":"Rejdak and colleagues then identified 22 patients who tested positive for SARS-CoV-2 and were taking either amantadine or memantine, and reported that none of these patients developed any clinical manifestations of COVID-19, nor did they report any significant change in their neurologic status [24]."}

{"project":"LitCovid-sentences","denotations":[{"id":"T107","span":{"begin":0,"end":300},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Rejdak and colleagues then identified 22 patients who tested positive for SARS-CoV-2 and were taking either amantadine or memantine, and reported that none of these patients developed any clinical manifestations of COVID-19, nor did they report any significant change in their neurologic status [24]."}

{"project":"2_test","denotations":[{"id":"32962001-32388458-44896019","span":{"begin":296,"end":298},"obj":"32388458"}],"text":"Rejdak and colleagues then identified 22 patients who tested positive for SARS-CoV-2 and were taking either amantadine or memantine, and reported that none of these patients developed any clinical manifestations of COVID-19, nor did they report any significant change in their neurologic status [24]."}

{"project":"LitCovid-PubTator","denotations":[{"id":"611","span":{"begin":41,"end":49},"obj":"Species"},{"id":"612","span":{"begin":74,"end":84},"obj":"Species"},{"id":"613","span":{"begin":165,"end":173},"obj":"Species"},{"id":"620","span":{"begin":108,"end":118},"obj":"Chemical"},{"id":"621","span":{"begin":122,"end":131},"obj":"Chemical"},{"id":"627","span":{"begin":215,"end":223},"obj":"Disease"}],"attributes":[{"id":"A611","pred":"tao:has_database_id","subj":"611","obj":"Tax:9606"},{"id":"A612","pred":"tao:has_database_id","subj":"612","obj":"Tax:2697049"},{"id":"A613","pred":"tao:has_database_id","subj":"613","obj":"Tax:9606"},{"id":"A620","pred":"tao:has_database_id","subj":"620","obj":"MESH:D000547"},{"id":"A621","pred":"tao:has_database_id","subj":"621","obj":"MESH:D008559"},{"id":"A627","pred":"tao:has_database_id","subj":"627","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Rejdak and colleagues then identified 22 patients who tested positive for SARS-CoV-2 and were taking either amantadine or memantine, and reported that none of these patients developed any clinical manifestations of COVID-19, nor did they report any significant change in their neurologic status [24]."}